Martin David P, Blachly Patrick G, McCammon J Andrew, Cohen Seth M
Departments of Chemistry and Biochemistry, ‡Pharmacology, and §Howard Hughes Medical Institute, University of California, San Diego , 9500 Gilman Drive, MC 0358, La Jolla, California 92093, United States.
J Med Chem. 2014 Aug 28;57(16):7126-35. doi: 10.1021/jm500984b. Epub 2014 Aug 19.
The binding of a series of metal-binding pharmacophores (MBPs) related to the ligand 1-hydroxypyridine-2-(1H)-thione (1,2-HOPTO) in the active site of human carbonic anhydrase II (hCAII) has been investigated. The presence and/or position of a single methyl substituent drastically alters inhibitor potency and can result in coordination modes not observed in small-molecule model complexes. It is shown that this unexpected binding mode is the result of a steric clash between the methyl group and a highly ordered water network in the active site that is further stabilized by the formation of a hydrogen bond and favorable hydrophobic contacts. The affinity of MBPs is dependent on a large number of factors including donor atom identity, orientation, electrostatics, and van der Waals interactions. These results suggest that metal coordination by metalloenzyme inhibitors is a malleable interaction and that it is thus more appropriate to consider the metal-binding motif of these inhibitors as a pharmacophore rather than a "chelator". The rational design of inhibitors targeting metalloenzymes will benefit greatly from a deeper understanding of the interplay between the variety of forces governing the binding of MBPs to active site metal ions.
对一系列与配体1-羟基吡啶-2-(1H)-硫酮(1,2-HOPTO)相关的金属结合药效基团(MBP)在人碳酸酐酶II(hCAII)活性位点的结合情况进行了研究。单个甲基取代基的存在和/或位置会极大地改变抑制剂的效力,并可能导致在小分子模型配合物中未观察到的配位模式。结果表明,这种意外的结合模式是甲基与活性位点中高度有序的水网络之间空间冲突的结果,该水网络通过形成氢键和有利的疏水接触而进一步稳定。MBP的亲和力取决于大量因素,包括供体原子的特性、方向、静电作用和范德华相互作用。这些结果表明,金属酶抑制剂的金属配位是一种可塑的相互作用,因此将这些抑制剂的金属结合基序视为药效基团而非“螯合剂”更为合适。深入了解控制MBP与活性位点金属离子结合的各种力之间的相互作用,将极大地有助于合理设计靶向金属酶的抑制剂。